As the tumor microenvironment can regulate stemness and therapeutic resistance of cancer cells [14], we determined that cancer cells with Crk-induced EMT did not possess enhanced levels of stem cell markers including Nanog, Sox2, Oct3/4, and CD44 (Supplementary information, Figure S13). The gene discussed is CRK; the disease is cancer.